Novel therapeutic strategies for rare mutations in non-small cell lung cancer.
Lung cancer is still the leading cause of cancer-related mortality. Over the past two decades, the management of non-small cell lung cancer (NSCLC) has undergone a significant revolution. Since the first identification of...
Read More